194 related articles for article (PubMed ID: 18285457)
1. Spatial interplay between PIASy and FIP200 in the regulation of signal transduction and transcriptional activity.
Martin N; Schwamborn K; Urlaub H; Gan B; Guan JL; Dejean A
Mol Cell Biol; 2008 Apr; 28(8):2771-81. PubMed ID: 18285457
[TBL] [Abstract][Full Text] [Related]
2. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
[TBL] [Abstract][Full Text] [Related]
3. SUMO-1 modification of PIASy, an E3 ligase, is necessary for PIASy-dependent activation of Tcf-4.
Ihara M; Yamamoto H; Kikuchi A
Mol Cell Biol; 2005 May; 25(9):3506-18. PubMed ID: 15831457
[TBL] [Abstract][Full Text] [Related]
4. PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies.
Sachdev S; Bruhn L; Sieber H; Pichler A; Melchior F; Grosschedl R
Genes Dev; 2001 Dec; 15(23):3088-103. PubMed ID: 11731474
[TBL] [Abstract][Full Text] [Related]
5. PIASy is a SUMOylation-independent negative regulator of the insulin transactivator MafA.
Onishi S; Kataoka K
J Mol Endocrinol; 2019 Nov; 63(4):297-308. PubMed ID: 31614335
[TBL] [Abstract][Full Text] [Related]
6. Protein inhibitor of activated STAT Y (PIASy) and a splice variant lacking exon 6 enhance sumoylation but are not essential for embryogenesis and adult life.
Wong KA; Kim R; Christofk H; Gao J; Lawson G; Wu H
Mol Cell Biol; 2004 Jun; 24(12):5577-86. PubMed ID: 15169916
[TBL] [Abstract][Full Text] [Related]
7. Modification of GATA-2 transcriptional activity in endothelial cells by the SUMO E3 ligase PIASy.
Chun TH; Itoh H; Subramanian L; Iñiguez-Lluhí JA; Nakao K
Circ Res; 2003 Jun; 92(11):1201-8. PubMed ID: 12750312
[TBL] [Abstract][Full Text] [Related]
8. Protein inhibitors of activated STAT (Pias1 and Piasy) differentially regulate pituitary homeobox 2 (PITX2) transcriptional activity.
Wang J; Sun Z; Zhang Z; Saadi I; Wang J; Li X; Gao S; Engle JJ; Kuburas A; Fu X; Yu W; Klein WH; Russo AF; Amendt BA
J Biol Chem; 2013 May; 288(18):12580-95. PubMed ID: 23515314
[TBL] [Abstract][Full Text] [Related]
9. PIASy-mediated sumoylation of Yin Yang 1 depends on their interaction but not the RING finger.
Deng Z; Wan M; Sui G
Mol Cell Biol; 2007 May; 27(10):3780-92. PubMed ID: 17353273
[TBL] [Abstract][Full Text] [Related]
10. PIASy mediates SUMO-2 conjugation of Topoisomerase-II on mitotic chromosomes.
Azuma Y; Arnaoutov A; Anan T; Dasso M
EMBO J; 2005 Jun; 24(12):2172-82. PubMed ID: 15933717
[TBL] [Abstract][Full Text] [Related]
11. PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress.
Mabb AM; Wuerzberger-Davis SM; Miyamoto S
Nat Cell Biol; 2006 Sep; 8(9):986-93. PubMed ID: 16906147
[TBL] [Abstract][Full Text] [Related]
12. Rod/Zw10 complex is required for PIASy-dependent centromeric SUMOylation.
Ryu H; Azuma Y
J Biol Chem; 2010 Oct; 285(42):32576-85. PubMed ID: 20696768
[TBL] [Abstract][Full Text] [Related]
13. Regulation of transforming growth factor-beta signaling by protein inhibitor of activated STAT, PIASy through Smad3.
Imoto S; Sugiyama K; Muromoto R; Sato N; Yamamoto T; Matsuda T
J Biol Chem; 2003 Sep; 278(36):34253-8. PubMed ID: 12815042
[TBL] [Abstract][Full Text] [Related]
14. PIASy-mediated sumoylation of SREBP1c regulates hepatic lipid metabolism upon fasting signaling.
Lee GY; Jang H; Lee JH; Huh JY; Choi S; Chung J; Kim JB
Mol Cell Biol; 2014 Mar; 34(6):926-38. PubMed ID: 24379443
[TBL] [Abstract][Full Text] [Related]
15. PIASy inhibits virus-induced and interferon-stimulated transcription through distinct mechanisms.
Kubota T; Matsuoka M; Xu S; Otsuki N; Takeda M; Kato A; Ozato K
J Biol Chem; 2011 Mar; 286(10):8165-8175. PubMed ID: 21199872
[TBL] [Abstract][Full Text] [Related]
16. The E3 SUMO ligase PIASy is a regulator of cellular senescence and apoptosis.
Bischof O; Schwamborn K; Martin N; Werner A; Sustmann C; Grosschedl R; Dejean A
Mol Cell; 2006 Jun; 22(6):783-794. PubMed ID: 16793547
[TBL] [Abstract][Full Text] [Related]
17. PIASy inhibits LRH-1-dependent CYP11A1 expression by competing for SRC-1 binding.
Hsieh HT; Wang CH; Wu ML; Yang FM; Tai YC; Hu MC
Biochem J; 2009 Apr; 419(1):201-9. PubMed ID: 19067654
[TBL] [Abstract][Full Text] [Related]
18. Chromatin remodeling: demethylating H3K4me3 of type I IFNs gene by Rbp2 through interacting with Piasy for transcriptional attenuation.
Yu X; Chen H; Zuo C; Jin X; Yin Y; Wang H; Jin M; Ozato K; Xu S
FASEB J; 2018 Feb; 32(2):552-567. PubMed ID: 28970247
[TBL] [Abstract][Full Text] [Related]
19. PIASy-mediated repression of the androgen receptor is independent of sumoylation.
Gross M; Yang R; Top I; Gasper C; Shuai K
Oncogene; 2004 Apr; 23(17):3059-66. PubMed ID: 14981544
[TBL] [Abstract][Full Text] [Related]
20. The interaction of Piasy with Trim32, an E3-ubiquitin ligase mutated in limb-girdle muscular dystrophy type 2H, promotes Piasy degradation and regulates UVB-induced keratinocyte apoptosis through NFkappaB.
Albor A; El-Hizawi S; Horn EJ; Laederich M; Frosk P; Wrogemann K; Kulesz-Martin M
J Biol Chem; 2006 Sep; 281(35):25850-66. PubMed ID: 16816390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
